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1 Introduction
It is essential to understand how recent advances in 
nanotechnology on nanolevel can enable and enhance 
progress in organ biofabrication on a macrolevel.  
Biofabrication could be defined as an application 
principle of engineering and information sciences for 
automated robotic bioassembly of living 3D human tissue 
and organs (Mironov et al., 2009a; Guillemot et al., 
2010; Hinton et al., 2017). In other terms, biofabrication 
is a biomedical application of additive manufacturing 
technology or computer-aided additive fabrication 
(Bracaglia et al., 2017). The concept of biofabrication 
was reappraised and redefined by Groll et al. (2016) as 
the automated generation of biologically functional 
products with the structural organization of living cells, 
bioactive molecules, biomaterials, cell aggregates such 
as micro-tissues, or hybrid cell-material constructs, 
through bioprinting or bioassembly and subsequent tissue 
maturation processes.
The emerging biofabrication research field is focused on 
using robotic automated engineering approaches in tissue 
bioassembly. Additive Manufacturing has transformed the 
global industry since automation and robotic techniques 
started to be employed with very high accuracy and 
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repeatability. Further the hardware, software incorporates 
algorithms for optimizing the process assuring high 
quality products.
The recent state of tissue engineering and the biofa-
brication could be compared to the situation of the mi-
croelectronic industry before and after the introduction of 
automated robotic technologies for fabricating microchips 
and microprocessors. The robotization and automation 
helped to convert emerging promising technologies into 
economically feasible industries. Moreover, it is logical 
to predict that industrial scale engineering of complex hu-
man organs is practically impossible without advances in 
robotization and automation of biofabrication process. 
Unquestionably, nanotechnology is one of the most 
relevant and rapidly emerging technologies of the XXI 
century (Roco, 2003). During the last decade, the expo-
nential growth of nanotechnology applications in the area 
of tissue engineering had been strongly observed (Gyles 
et al, 2017; Rabionet et al., 2017). Concerning published 
contents devoted to tissue engineering field in the last ten 
years, the number of publications has been also drama-
tically augmented (Mironov et al., 2008a,b; Mironov et 
al., 2009a,b; Lionetti et al., 2011; Rezende et al., 2012; 
Perán et al., 2012). A quick systemic analysis consult on 
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PUBMED online database regarding the terms “nanotech-
nology” and “tissue engineering” showed that the number 
of publications of these fields is crescent over the years 
(Fig. 1). 
The most considerable and non-trivial related to the in-
terface of tissue engineering and nanotechnology is: “how 
can the use of materials (on nanolevel) enable biofabrica-
tion of human organs (on macrolevel)? ”.
One of the most important points in the hybrid process 
is the wide range of usable materials. The materials can 
go from metals, ceramics, polymers (natural and/or syn-
thetics) until composites mixing these groups. Looking at 
the biofabrication aspects ceramics and mainly polymers 
are highly used. On hybrid processes involving a 3D bio-
printer and electrospinning as main topics in this paper, in 
general, the most common materials applied are alginate, 
collagen, chitosan, starchs as being the natural ones plus 
PCL (poly caprolactone), PLA (poly lactid acid), PLLA 
(poly L-lactic acid), PDLA (poly D-lactic acid), PLGA 
(poly lactide-co-glycolide) as the synthetic ones.
Therefore, the objective of this review is a presenta-
tion of how the most recent advances in the application of 
nanomaterials in tissue engineering can enable the robotic 
and automated biofabrication of 3D human tissues and or-
gans which have macrolevel organization. The challenges 
and prospects of nanomaterials application in tissue engi-
neering and nanotechnological strategies in organ biofab-
rication will also be discussed. 
We would like especially to emphasize that this is 
not a comprehensive review about nanotechnology in 
tissue engineering, but rather focused attempt to ex-
plore the emerging potential of applications of nan-
otechnology to predominantly organlevel of tissue 
engineering or, more specifically, for organ biofabrica-
tion and how this nanoscale contribute to createthese 
three-dimensional structures that have a macroscale. 
Figure 1 -  A chart illustrating the times the terms “nanotechnology and tissue engineering“ appear on PUBMED database
2. Nanofibers
The electrospinning technique has appeared as a relatively 
simple and scalable nanotechnological method for the 
generation of nanostructured scaffolds (Hidalgo et al., 2013). 
Electrospinning allows controlling the diameter of the 
spun fibers and can produce nanofibers and scaffolds that 
mimic the nanostructure of natural extracellular matrices 
(ECMs), as confirmed by a more efficient vascular cell 
attachment and spreading (Lee et al., 2007).
The general aspects of the electrospinning technology 
have been substantially reviewed elsewhere (Murugan and 
Ramakrishna, 2006; Barnes et al., 2007; Murugan et al., 
2007a; Mironov et al., 2008a,b,c, Hidalgo et al., 2013; 
Braghirolli et al., 2014). Considerable attention will be 
given on the usage of the electrospinning technology in the 
field of vascular tissue engineering (Kitsara et al., 2017). 
A wide range of synthetic polymers has been successfully 
applied in the electrospinning technique. Furthermore, 
electrospinning of natural proteins, such as collagen and 
elastin, either alone or as in blends with synthetic polymers, 
has been published (Boland et al., 2004; Lee et al., 2007; 
Aguirre-Chagala et al., 2017). However, the reported 
stability of vascular scaffolds created by electrospinning 
of merely natural proteins had not reached desirable levels 
yet (Ma et al., 2008).
Although dense nanofiber meshworks provide 
excellent conditions for cell attachment and the spreading 
of endothelial cells on the luminal surface of the scaffold 
(Bondar et al., 2008), they also preclude effective cell 
migration into the scaffold and thus impede smooth 
muscle cell migration and the sequential formation of 
muscular layers inside the vascular tissue engineered 
constructs. Electrospinning allows the fabrication of a 
wide variety of nanofibers and nanostructured scaffolds 
with special characteristics and functionalities. The 
obtained nanofibers vary in shape, size and composition: 
they can be solid, composite, hollow, porous, decorated, 
helical and branched. This diversity of possible 
electrospun nanofibers offers interesting opportunities for 
the enhancement of vascular-scaffold functionality. For 
example, the hollow nanofibers and nanoshells created by a 
coaxial extruder, as well as composite-coated or decorated 
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nanofibers, could provide additional functionalities, 
including the capacity to release oxygen and to present 
growth factors and RGD peptides (Zhu et al., 2017).
However, the full potential of electrospinning for the 
engineering of the full array of nanofibers with different 
functionalities remains to be explored. Significant 
progress has already been made related to the control of 
the fiber orientation (Murugan and Ramakrishna, 2007b), 
which is an important step toward the rational design 
of biomimetic vascular scaffolds. Nevertheless, in our 
opinion, controlling only the orientation of the nanofiber 
will probably not be enough. The recapitulation of the 
entire matrix architecture and the non-linear biomechanical 
behavior of the natural vascular wall are dramatically 
crucial. The most exciting advance in electrospinning is 
the successful one-step rapid fabrication of a vascular 
scaffold with integrated living cells (Stankus et al., 2006). 
In these studies, the previously reported methods for the 
encapsulation of living cells were combined with the 
electrospinning of nanofibers into one procedure. Further 
optimization of this electrospinning strategy might offer 
the greatest potential for rapid biofabrication of vascular-
tissue constructs and might eventually eliminate the need 
for time-consuming and expensive bioreactor-based 
cell seeding and scaffold cellularization. Although this 
impressive progress in vascular tissue engineering with 
the help of innovative electrospinning technologies has 
occurred, rapid cell integration into scaffolds and their 
optimal mechanical properties remain the main defiance.
The nanostructured electrospun matrices are an 
excellent substrate for fabrication of transplantable 
cell monolayer due to the biomimicking character of 
nanofibers; moreover, the resulted optimal conditions for 
cell attachment and spreading could compete with scaffold-
free cell sheet technology (Hidalgo et al., 2013).  The 
potential functionalization of electrospun matrices and 
their transformation into drug-eluting scaffold provides 
another advantage (Zhan et al., 2017). 
On the other hand, dense electrospun nanostructured 
matrices usually do not present optimal properties for 
the cell invasion and effective cell seeding. Theoretically, 
it is possible to fabricate matrices with larger pores 
using additional spinning of sacrificial fibers or cryo-
electrospinning (Kamoun et al., 2017). However, the 
attempts to increase pore sizes and make adequate 
electrospun matrices for cell invasion and cell seeding 
could negatively impact on the material properties of 
matrices. The efficient solution of these two interdependent 
problems represents the main challenge in development and 
clinical translation and commercialization of electrospun 
technology in tissue engineering. The hybrid composite 
approach opens possible solution in the fabrication of 
electrospun matrices with desirable natural-like material 
properties. The development of electrospinning apparatus 
with two nozzles (for example, one for fabrication collagen 
mimicking nano and microfibers and one for fabrication 
elastin mimicking nano and microfibers) in combination 
with modified fiber collector with changeable diameter 
will allow fabricating wavy collagen mimicking nanofibers 
and biomechanically compliant composite vascular graft.
Coaxial and rotational electrospinning allows the 
biofabrication of a new vascular graft (Fig. 2). This type 
of equipment not only allows mixing different types of 
polymers, or to place layers of different types of polymers, 
but also allows obtaining different rates of degradation 
Figure 2 - (A) Schematic of side-by-side nozzle configuration. Two capillaries containing different polymer solutions are set side-by-
side. As long as the two solutions have similar conductivities, a single Taylor cone will be developed, and a fiber jet containing both 
polymers will be produced. However, the relative amounts of each polymer can vary along the electrospun fiber. Also, schematic 
of coaxial nozzle configuration. A smaller capillary is set inside a larger capillary such that the long axes of the capillaries coincide. 
Different polymer solutions are passed through each capillary. At the tip of the capillaries the Taylor cone is formed and leads to 
the formation of fibers in which one polymer fiber is encapsulated within another (known as a core-shell morphology). (B) The 
rotational collector can be used with a unique polymer solution, but also permits to have two (or more) nozzles with different 
polymer solutions. 
auricular implant. Another promising direction is using 
drug-eluting nanofibers which will enable fabrication cost-
effective cell-free hybrid dual scale scaffolds with optimal 
mechanical properties, superior biocompatibilities, and 
capacities for induced endogenous regeneration. The cell-
free complaint electrospun scaffold has been shown to 
be promising in case of vascular tissue engineering (Wu 
et al., 2012). Drug-eluting electrospun vascular scaffold 
has been also reported recently (Innocente et al., 2009). It 
has been shown recently that cell-free bioprinted drug-
eluting scaffold can induce the formation of cartilage 
in vivo (Lee et al., 2010). Thus, cell-free drug-eluting 
dual scale biomechanically optimal and biocompatible 
scaffold fabricated with using hybrid FDM and 
electrospinning technology with capacities for induced 
endogenous regeneration could lead to the development 
of economically cost-effective implants and scaffolds. In 
case of using cell-free scaffolds or even non-biodegradable 
complaint and biocompatible implants fabricated by above 
described hybrid dual scale scaffold technology, it will be 
much easier to get required regulatory approval, and an 
accelerate desirable clinical and commercial translation. 
Moreover, the other significant advantage that is achieved 
with this type of hybrid system is that different types of 
materials can be mixed, and 3D structures can be created 
where layers of materials can be deposited using the 
two techniques, that is, it can be used the material for 
FDM deposition and another for electrospinning. Also, a 
layer can be made by FDM and then place a layer using 
electrospinning and create sandwich-like structures, which 
may even allow obtaining systems with different rates of 
degradation (Fig. 4).
Other advantages that have been experienced through 
electrospinning are the incorporation of nanoparticles 
of inorganic compounds such as hydroxyapatite (HA), 
or metal particles such as silver (Ag). In the polymer 
solutions, these nanoparticles are dispersed, for which 
use can be made of some dispersing agent that does not 
allow their agglomeration, and they are dispersed through 
the fibers. In addition, given its nature, it is possible to 
increase the conductivity of the solution and achieve a 
good integration of the particles inside the fibers, as shown 
in Figure 5. In this figure, it can observe the external 
morphology of the fibers by SEM and the inner of these 
fibers by TEM showing the presence of the nanoparticles 
(HA and Ag) distributed around the fibers. This is evidence 
that through this technique, there are many hybrid type 
systems that can be obtained, in addition to the possible 
incorporation of drugs or biomolecules in the inner of the 
fibers as evidenced by several scientific papers reported 
(Balogh et al, 2015).
Figure 4 - SEM micrographs of the double scale scaffold. (a) PCL 3D scaffold obtained by FDM, where macropores are shown. 
(b) Image of the combined system after deposition of PLA (poly lactic acid) micro and nanofibers using electrospinning. These 
filaments show a preferred orientation and cover macropores created by Additive Manufacturing (FDM technique). (c) and (d) 
details show the good adhesion of the filaments deposited by electrospinning on the previously created scaffold by FDM. These 
structures allow not only the combination of scaffolding techniques, but also the combination of polymers. (Images supplied by 
B5IDA research group, Universidad Simon Bolivar, Venezuela).
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as well as the possibility of encapsulating different types 
of molecules (drugs, biomolecules, etc.). For example, 
the development of compliant composite drug eluting 
athrombogenic vascular graft with capacities of recruiting 
cells in vivo is one of the most promising approaches in 
vascular tissue engineering.  Rolling, stacking and folding 
including cell-driven self-folding as a concept of 4D 
bioprinting (Li et al., 2016; An et al., 2016; Gao et al., 2016) 
of electrospun matrices offer interesting opportunities for 
designing and engineering tissue engineering constructs 
of complex geometry (Cheng et al., 2017, Mokhena and 
Luyt, 2017).
3. Hybrid fused deposition modeling and electros-
pinning nanofibrous technology
Combination of electrospinning with fused deposition 
modeling (FDM) opens a new opportunity for designing 
dual scale scaffold suitable for biofabrication of 3D tissue 
and organs (Fig. 3). Electrospinning dues to the biomimetic 
character of nanofibers provide superior matrices for cell 
attachment and biocompatibility, but material properties 
of electrospun matrices are inferior, and capacities for 
engineering 3D tissue constructs are limited. FDM 
allows fabricating 3D tissue engineered scaffolds of 
desirable patient-specific 3D shape and provides superior 
biomimetic material properties and better mechanical 
properties, but due to the large size of pores, the cell 
seeding is usually not optimal or time-consuming. Hybrid 
FDM and electrospinning dual scale scaffold technology 
eliminates limitation of both technologies and provides 
desirable synergistic beneficial effect (Park et al., 2008). 
One of the possible applications of hybrid technology 
is the fabrication of an auricular implant with 
optimal biomimetic material properties and enhanced 
biocompatibility. Patient specific computer-aided design 
of, for example, an auricular implant could be developed 
based on using laser scanning of the external ear (Wen et al., 
2008) and customized auricular implant could be fabricated 
by additive manufacturing technology such as a FDM and 
electrospinning will enhance the biocompatibility of the 
Figure 3 - Proposal of 3D dual scale polymer scaffolds (or hybrid scaffolds) produced by FDM 3D additive manufacturing technology 
and electrospinning (SEM micrographs supplied by B5IDA research group, Universidad Simon Bolivar, Venezuela) (Figure adapted 
from Sabino et al., 2017).
4. Conclusion and Future Perspectives
Nanotechnology applied in the tissue engineering field 
is rapidly evolving an ongoing process. As we tried to 
illustrate in this review paper, there is also strong potential 
for successful application of nanotechnology in human 
organ biofabrication which has macrolevel organization. 
Nevertheless, the researchers on the intersection 
between the nanotechnology and the tissue engineering are 
still encountering some serious barriers. The first and most 
evident one is the toxicology of the nanomaterials.
Thus, the biocompatibility of nanomaterials for 
tissue engineering application must be seriously taken 
into account. The second challenge concerns the 
functionalization of the nanomaterials. Recent progress 
in designing drug-eluting nanofibers using coaxial 
electrospinning is a suitable example of evolution.
The third challenge is related to the design, synthesis 
and production of novel nanomaterials with biomimetic 
aspects. This trend is already evident in the fabrication 
of nanofibers using electrospinning technology. The 
development of composite nanomaterials is one of the 
most promising approaches in this direction.
The fourth challenge is the standardization of 
nanomaterials. In a wider view, to the achievement of 
the product certification, it is extremely necessary the 
standardization on certain stage of development of any 
emerging technology.
In the future, perspective functional biomimetic 
nanomaterials can enable regenerative medicine that means 
healing from inside and therefore decrease the necessity 
for tissue engineering ex vivo. Drug-eluting electrospun 
vascular graft is one possible example of this tendency. 
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